packageZongertinib

zongertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Zongertinib is an anticancer drug, a HER2 tyrosine kinase inhibitor being developed for cancer treatment. It is approved and also under investigation, but details on where it is marketed are not available.

Summary written by glm-5.3-flash from Wikidata Q135706605 and the WHO ATC classification; not checked by a person.

name:zongertinib
ATC codes:L01EH04
DrugBank:DB18762
PubChem CID:160283094
Wikidata:Q135706605
formula:C29H29N9O2
molar mass:535.612 g/mol (PubChem CID 160283094)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown